Screener
ADMA Biologics ADMA Net debt / EBITDA
Net debt / EBITDA at other companies
Other financials
Where this comes from
Calculated from ADMA Biologics’s reported figures.
Based on the most recent quarter.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
FAQ
- What is ADMA Biologics's net debt / EBITDA?
- ADMA Biologics (ADMA) reported net debt / EBITDA of 0.3× in Q2 2026.
- How has ADMA Biologics's net debt / EBITDA changed year-over-year?
- ADMA Biologics's net debt / EBITDA increased by 159.9% year-over-year, from -0.5× to 0.3×.
- What is the long-term trend for ADMA Biologics's net debt / EBITDA?
- Over 2 years (2023 to 2025), ADMA Biologics's net debt / EBITDA has grown at a -83.2% compound annual growth rate (CAGR), from -1.4× to -0×.
- What does net debt / EBITDA mean?
- Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.
Ask your AI about ADMA Biologics's net debt / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude